2.47 (-%)
As of Oct 31, 2024
Source:
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company engaged in drug research and development to create new therapies for fibrotic disease, cancer and selected other diseases. Our drug candidates are based on our method of targeting galectin proteins, which are key mediators of biologic and pathologic functions.
| Country | United States |
| Headquarters | norcross, georgia |
| Phone Number | 678-620-3186 |
| Industry | manufacturing |
| CEO | Joel Lewis |
| Website | www.galectintherapeutics.com |